TIBER CREEK GROUP for PHRMA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to pharmaceutical drug pricing and transparency. S. 1348 - SPIKE Act of 2017. S. 637 - C-THRU Act of 2017. Issues related to the illegal importation of prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
Medicare/Medicaid MMM
Issues related to Part B average sale price payment reform. Issues related to Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
Budget/Appropriations BUD
H.R.5786 - Military Construction, Veterans Affairs, and Related Appropriations Act, 2019, 2019. H.R.5895 - Energy and Water, Legislative Branch, and Military Construction and Veterans Affairs Appropriations Act, 2019. H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. Issues related to the FDA and drug compounding. Issues related to prescription drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LEFFINGWELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.